Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CARTO® 3 System and Real Time Intracardiac Ultrasound for Ablation of Drug Refractory Recurrent Symptomatic Paroxysmal AF: Acute Procedural Outcomes Study

NCT01716663 is registered in ClinicalTrials.gov with Biosense Webster, Inc. as lead sponsor.

NCT NCT01716663
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01716663 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CARTO® 3 System and Real Time Intracardiac Ultrasound for Ablation of Drug Refractory Recurrent Symptomatic Paroxysmal AF: Acute Procedural Outcomes Study
Lead sponsor
Biosense Webster, Inc.
Phase
Observational
Overall status
Completed
Start date
October 31, 2012
Completion date
September 30, 2013
Enrollment
234 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, paroxysmal af